MicroRNA associated with dyslipidemia and coronary disease in humans.

MicroRNAs are structural components of an epigenetic mechanism of posttranscriptional regulation of messenger RNA translation. Recently, there has been significant interest in the application of microRNA as a blood-based biomarker of underlying physiological conditions. Dyslipidemia is a complex, heterogeneous condition conferring substantially increased risk for cardiovascular disease. The purpose of this review is to describe the current body of knowledge on the role of microRNA regulation of lipoprotein metabolism in humans and to discuss relevant methodological and study design considerations. We highlight the potential roles for microRNA in gene-environment interactions.

[1]  A. Näär,et al.  MicroRNAs in metabolism and metabolic disorders , 2012, Nature Reviews Molecular Cell Biology.

[2]  L. Zitvogel,et al.  Inflammasomes in carcinogenesis and anticancer immune responses , 2012, Nature Immunology.

[3]  M. Pfaffl,et al.  Profound Effect of Profiling Platform and Normalization Strategy on Detection of Differentially Expressed MicroRNAs – A Comparative Study , 2012, PloS one.

[4]  L. Goedeke,et al.  MicroRNAs in metabolic disease. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[5]  S. H. Najafi-Shoushtari.  MicroRNAs in Cardiometabolic Disease , 2011, Current atherosclerosis reports.

[6]  E. Lai.  Micro RNAs are complementary to 3′ UTR sequence motifs that mediate negative post-transcriptional regulation , 2002, Nature Genetics.

[7]  Heidi J. Peltier,et al.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. , 2008, RNA.

[8]  Jiayin Dai,et al.  Association of perfluorooctanoic acid with HDL cholesterol and circulating miR-26b and miR-199-3p in workers of a fluorochemical plant and nearby residents. , 2012, Environmental science & technology.

[9]  Ryan E. Temel,et al.  Inhibition of miR-33 a / b in non-human primates raises plasma HDL and lowers VLDL triglycerides , 2011 .

[10]  A. Bas,et al.  Utility of the Housekeeping Genes 18S rRNA, β‐Actin and Glyceraldehyde‐3‐Phosphate‐Dehydrogenase for Normalization in Real‐Time Quantitative Reverse Transcriptase‐Polymerase Chain Reaction Analysis of Gene Expression in Human T Lymphocytes , 2004, Scandinavian journal of immunology.

[11]  R. Hegele,et al.  Gene-gene and gene-environment interactions: new insights into the prevention, detection and management of coronary artery disease , 2009, Genome Medicine.

[12]  F. Marincola,et al.  Influence of Quercetin-Rich Food Intake on microRNA Expression in Lung Cancer Tissues , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[13]  Frank Speleman,et al.  A novel and universal method for microRNA RT-qPCR data normalization , 2009, Genome Biology.

[14]  Anindya Dutta,et al.  Small RNAs with Imperfect Match to Endogenous mRNA Repress Translation , 2003, Journal of Biological Chemistry.

[15]  Zhijian Yang,et al.  Plasma levels of lipometabolism-related miR-122 and miR-370 are increased in patients with hyperlipidemia and associated with coronary artery disease , 2012, Lipids in Health and Disease.

[16]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[17]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[18]  G. Illei,et al.  The Majority of MicroRNAs Detectable in Serum and Saliva Is Concentrated in Exosomes , 2012, PloS one.

[19]  S. Gabriel,et al.  Assessing the impact of population stratification on genetic association studies , 2004, Nature Genetics.

[20]  E. Greer,et al.  Histone methylation: a dynamic mark in health, disease and inheritance , 2012, Nature Reviews Genetics.

[21]  K. Moore,et al.  miR-33a/b contribute to the regulation of fatty acid metabolism and insulin signaling , 2011, Proceedings of the National Academy of Sciences.

[22]  H. Augustin,et al.  Histone Deacetylase 9 Promotes Angiogenesis by Targeting the Antiangiogenic MicroRNA-17–92 Cluster in Endothelial Cells , 2013, Arteriosclerosis, Thrombosis and Vascular Biology.

[23]  Mario Pazzagli,et al.  Quantitative real-time reverse transcription polymerase chain reaction: normalization to rRNA or single housekeeping genes is inappropriate for human tissue biopsies. , 2002, Analytical biochemistry.

[24]  S. Varma,et al.  Protective effect of caffeine against high sugar-induced transcription of microRNAs and consequent gene silencing: A study using lenses of galactosemic mice , 2013, Molecular vision.

[25]  Stefanie Dimmeler,et al.  Members of the microRNA-17-92 cluster exhibit a cell-intrinsic antiangiogenic function in endothelial cells. , 2010, Blood.

[26]  J. Ioannidis,et al.  Replication validity of genetic association studies , 2001, Nature Genetics.

[27]  Takeshi Kimura,et al.  MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo , 2010, Proceedings of the National Academy of Sciences.

[28]  T. Shioda,et al.  MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis , 2010, Science.

[29]  Jan Hellemans,et al.  miRNA expression profiling: from reference genes to global mean normalization. , 2012, Methods in molecular biology.

[30]  Goutam Ghosh Choudhury,et al.  miR-21 is targeted by omega-3 polyunsaturated fatty acid to regulate breast tumor CSF-1 expression. , 2012, Carcinogenesis.

[31]  J. Mckenney,et al.  National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) , 2002 .

[32]  Toshiko Tanaka,et al.  Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. , 2013, American journal of human genetics.

[33]  E. Flowers,et al.  MicroRNA associated with atherogenic dyslipidemia in South Asian men. , 2012, International journal of cardiology.

[34]  Ana Kozomara,et al.  miRBase: integrating microRNA annotation and deep-sequencing data , 2010, Nucleic Acids Res..

[35]  J. VandeBerg,et al.  Differential microRNA response to a high-cholesterol, high-fat diet in livers of low and high LDL-C baboons , 2012, BMC Genomics.

[36]  M. Satoh,et al.  MicroRNA-34 a regulates the longevity-associated protein SIRT 1 in coronary artery disease : effect of statins on SIRT 1 and microRNA-34 a expression , 2012 .

[37]  Daniel B. Martin,et al.  Circulating microRNAs as stable blood-based markers for cancer detection , 2008, Proceedings of the National Academy of Sciences.

[38]  Lianbo Yu,et al.  Detection of microRNA Expression in Human Peripheral Blood Microvesicles , 2008, PloS one.

[39]  Qing Wu,et al.  miREnvironment Database: providing a bridge for microRNAs, environmental factors and phenotypes , 2011, Bioinform..

[40]  K. Moore,et al.  The role of microRNAs in cholesterol efflux and hepatic lipid metabolism. , 2011, Annual review of nutrition.

[41]  Ashish Choudhary,et al.  A novel mean-centering method for normalizing microRNA expression from high-throughput RT-qPCR data , 2011, BMC Research Notes.

[42]  A. Segura‐Carretero,et al.  Plant-derived polyphenols regulate expression of miRNA paralogs miR-103/107 and miR-122 and prevent diet-induced fatty liver disease in hyperlipidemic mice. , 2012, Biochimica et biophysica acta.

[43]  A. Disch,et al.  Reference genes for the relative quantification of microRNAs in renal cell carcinomas and their metastases. , 2011, Analytical biochemistry.

[44]  S. Shankar,et al.  Epigenetic modifications by dietary phytochemicals: implications for personalized nutrition. , 2013, Pharmacology & therapeutics.

[45]  Aaron N. Chang,et al.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. , 2011, The Journal of clinical investigation.

[46]  L. De Cecco,et al.  Comparison of Microarray Platforms for Measuring Differential MicroRNA Expression in Paired Normal/Cancer Colon Tissues , 2012, PloS one.

[47]  Ying I. Wang,et al.  IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal , 2012, Circulation research.

[48]  B. Burwinkel,et al.  Characterization of extracellular circulating microRNA , 2011, Nucleic acids research.

[49]  Peter A. Jones.  Functions of DNA methylation: islands, start sites, gene bodies and beyond , 2012, Nature Reviews Genetics.

[50]  Sharon R Grossman,et al.  Integrating common and rare genetic variation in diverse human populations , 2010, Nature.

[51]  D. Karolina,et al.  Circulating miRNA profiles in patients with metabolic syndrome. , 2012, The Journal of clinical endocrinology and metabolism.

[52]  E. Flowers,et al.  MicroRNA regulation of lipid metabolism. , 2013, Metabolism: clinical and experimental.

[53]  X. Chen,et al.  Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases , 2008, Cell Research.

[54]  Taous Khan,et al.  MicroRNAs: synthesis, mechanism, function, and recent clinical trials. , 2010, Biochimica et biophysica acta.

[55]  E. Flowers,et al.  Measurement of MicroRNA , 2013, Biological research for nursing.

[56]  Elena Flowers,et al.  Gene-environment interactions in cardiovascular disease , 2012, European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology.

[57]  M. Satoh,et al.  MicroRNA-34a regulates the longevity-associated protein SIRT1 in coronary artery disease: effect of statins on SIRT1 and microRNA-34a expression. , 2012, Clinical science.

[58]  K. Moore,et al.  MicroRNAs regulating lipid metabolism in atherogenesis , 2012, Thrombosis and Haemostasis.

[59]  K. Moore,et al.  MicroRNA modulation of cholesterol homeostasis. , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[60]  David J. Galas,et al.  Comparing the MicroRNA Spectrum between Serum and Plasma , 2012, PloS one.

[61]  Robert A. Hegele,et al.  Plasma lipoproteins: genetic influences and clinical implications , 2009, Nature Reviews Genetics.

[62]  Tae Hyun Kim,et al.  Decrease of microRNA‐122 causes hepatic insulin resistance by inducing protein tyrosine phosphatase 1B, which is reversed by licorice flavonoid , 2012, Hepatology.

[63]  P. Donnelly,et al.  The effects of human population structure on large genetic association studies , 2004, Nature Genetics.